|
|
楼主 |
发表于 2025-2-6 15:36:45
|
显示全部楼层
本帖最后由 NatureBoy 于 2025-2-6 16:03 编辑 7 Q0 s! ]8 b$ s0 f1 ^
; V- U. D: n9 I$ ^
今年的ISC大会Late-Breaking Science（重磅研究）已经出炉，国内单位入选情况
! Q" J+ h; B+ H) N: F! G8 ?/ u) d7 ?
LB2. TransRadial versus transfemoral Arterial access for CErebral angiography
4 f; @% @' ? e! L0 S ^Wei Ni, Huashan Hospital, Fudan University, Shanghai, China
2 b+ l( U9 @- u0 c8 `/ ^9 d/ J
' r5 Z, R' b; [6 MLB17. Intensive Blood Pressure Lowering After Thrombectomy in Ischemic Stroke Patients-A Randomized Clinical Trial
' z2 B7 O% D2 y8 g; VXuening Zhang, West China Hospital, Sichuan University, Chendu, China
" f/ {1 j" ?* _7 r9 @) ^5 S) v4 i3 G
LB38. Intra-arterial Tenecteplase thrombolysis for acute LVO after successful mechanical thrombectomy recanalization (ANGEL-TNK) — A Multicenter, Prospective, Randomized, Open-label, Blinded End-point Trial
5 g% G1 ?0 C7 r# vMiao Zhongrong, Beijing Tiantan Hospital, Beijing, China
! |- @7 \$ g* g1 V; Q1 w' L/ v* Q
" ~6 P9 B9 w& b- eLB39. The Optimal Dosage of ADjunctive Intra-Arterial Tenecteplase following Successful Endovascular Thrombectomy in Patients with Large Vessel Occlusion Acute Ischemic Stroke (DATE) Trail
; D2 U. q2 j5 F/ w M* {Xianhua Hou, The First Affiliated Hospital, Army Medical University, Chongqing, China
5 a1 y9 U: l, g: \: {7 D
9 T; Y7 [3 s) g% y* ?. N: l) KLB41. Treatment with intravenous alteplase in ischemic stroke patients with onset time between 4.5 and 24 hours5 A, P( y' P0 z3 _8 n t, J2 B
Min Lou, The Second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China
' O. J3 \6 b+ i) F' I c/ b: u) v; ^ P( z( T4 s
LB42. Intra-arterial Alteplase for Acute Ischemic Stroke After Mechanical Thrombectomy (PEARL): A Multicenter Randomized Trial# H0 b) Z# }3 H( r6 g
Yamei Tang, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China; V6 ~7 E: S4 F
) y9 S; i8 u* q8 [
LB44. Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients with Type 2 Diabetes Mellitus (LAMP): A Randomized Clinical Trial
1 U% c8 B8 u3 j XHuili Zhu, The First Affiliated Hospital of Jinan University, Guangzhou, China4 p# D7 \& R5 X" Q2 ~
~. h( T3 |, G( r
LB45. BXOS110 for Acute Ischemic Stroke Treatment (BEST): A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
) X6 z- S; ~1 BYarong Ding, Beijing Tiantan Hospital, Beijing, China3 L {8 G, H+ {; ~' w; X7 i' o4 W
: \$ q6 d1 E& L1 T
祝贺以上单位！0 `# G5 s1 H2 Q2 y+ V9 G- M" ]/ O
|
|
发表于 2025-2-6 15:11:41
发表于 2025-2-6 15:40:38
